Provided by NYU Langone Health NEW YORK, Feb. 17, 2022 /PRNewswire/ — There are more than 3.4 million adults and children in the United States with active epilepsy, and about one million of those experience seizures that are unable to be controlled by medicine. To further understand this intractable form of epilepsy, NYU Langone Health…
High Performing Algorithm To Translate Paralyzed Patients’ Thoughts Into Real-Time Prosthetic Movements Blackrock Neurotech to enhance thought-to-prosthetic movement for paralyzed BCI patients by licensing proprietary algorithm from Columbia University. SALT LAKE CITY, Feb. 8, 2022 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface (BCI) technology, has signed an exclusive license for Columbia University’s neural decoder MINT. The license…
Groundbreaking Brain Computer Interface Technology Expected to Achieve Partial Restoration of Communication Function in Impaired Patients SALT LAKE CITY, Nov. 30, 2021 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface (BCI) technology, has announced plans to commercialize a BCI platform in 2022, with the aim of restoring communication function in patients impaired by disabilities…
Blackrock Neurotech’s MoveAgain Brain-Computer Interface System Receives Breakthrough Device Designation from the FDA SALT LAKE CITY, Nov. 16, 2021 /PRNewswire/ — Blackrock Neurotech, the leader in brain-computer interface technology, today announces that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device designation for its groundbreaking MoveAgain Brain Computer Interface (BCI) System. The first-of-its-kind system is…
Hearing Restoration For The Deaf: Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL SALT LAKE CITY, Sept. 15, 2021 /PRNewswire/ — Blackrock Neurotech, a leading provider of brain computer interface (BCI) technology for human patients, has announced plans to invest in a novel auditory nerve implant (ANI) device that restores hearing…
Blackrock Neurotech, ClearPoint Neuro to Address Neurological Disorders With Novel Brain-Computer Interface Surgical Solution SOLANA BEACH, Calif. and SALT LAKE CITY, July 21, 2021 (GLOBE NEWSWIRE) — ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced a joint agreement with Blackrock Neurotech to…
Blackrock Neurotech and CorTec are now collaboration partners CorTec GmbH (CorTec) and Blackrock Neurotech, LLC announced today that they have entered into a transatlantic strategic partnership, combining Blackrock Neurotech’s industry-leading experience in delivering brain computer interface (BCI) systems with CorTec’s portfolio of cutting-edge neurodevices to accelerate access to researchers, open new markets, and expand applications…
SALT LAKE CITY, May 19, 2021 /PRNewswire/ — Blackrock Neurotech, the world’s leading platform for brain-computer interface (BCI) technology and manufacturing, has closed a $10 million financing round, led by Christian Angermayer’s re.Mind Capital with participation from Peter Thiel, German entrepreneur Tim Sievers, and Sorenson Impact’s University Venture Fund II. Christian Angermayer and Jan Hardorp…
SALT LAKE CITY, May 13, 2021 /PRNewswire/ — Blackrock Microsystems, a privately held company that provides enabling tools for neuroscience, neural engineering and neuroprosthetics research worldwide partnered with a team of interdisciplinary researchers at Northwestern University, who signed a contract with the Defense Advanced Research Projects Agency (DARPA) to develop a wireless, fully implantable device…
Blackrock Microsystems Supports an Ambitious European Union Funded Partnership for Brain-Computer-Interface Connectivity This collaboration merges Blackrock’s brain-computer interface technology to create the first battery-free, high-speed, and wireless in-body communication platform for brain-machine-body connectivity. SALT LAKE CITY, UT (March 18,2021) — Blackrock Microsystems, the world leading brain-computer interface (BCI) technology innovator and manufacturer, announces today the…
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |